Key Highlights from Eli Lilly's Q1 2024 Earnings: Revenue Surges 26%

Tuesday, 30 April 2024, 12:55
Eli Lilly (LLY) reported strong first quarter 2024 earnings results with worldwide revenue reaching $8.77 billion, a notable 26% increase from the previous year. The growth was primarily driven by a 16% increase in volume and a 10% rise in realized prices. Net income rose by 67% to $2.24 billion, with adjusted EPS increasing by 59% to $2.58. The company projects a promising full-year 2024 with revenue expected between $42.4 billion to $43.6 billion and EPS estimates ranging from $13.05 to $14.00.
https://store.livarava.com/26bc6a7f-06f1-11ef-a6c0-63e1980711b2.jpg
Key Highlights from Eli Lilly's Q1 2024 Earnings: Revenue Surges 26%

Eli Lilly (LLY) Q1 2024 Earnings Highlights

Eli Lilly and Company (NYSE: LLY) released its first quarter 2024 earnings report, showing significant growth in revenue. Worldwide revenue stood at $8.77 billion, marking a substantial 26% increase compared to the previous year. This growth was fueled by a 16% rise in volume and a 10% boost from higher realized prices.

Reported net income soared by 67% to $2.24 billion, translating to $2.48 per share. Additionally, adjusted EPS climbed by 59% to $2.58. Looking ahead, the company anticipates revenue for the full-year 2024 to range between $42.4 billion and $43.6 billion. The reported EPS is expected to fall within $13.05 to $13.55, while adjusted EPS is estimated to be in the $13.50 to $14.00 range.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe